2 1 Shi Ji Jing Ji Bao Dao·2025-09-18 02:21Group 1 - The core viewpoint of the article highlights the target price increases for several listed companies, with notable gains for Haier Biomedical, Sanlian Hongpu, and Laofengxiang, showing increases of 32.81%, 32.56%, and 30.70% respectively, across the medical device, professional engineering, and jewelry sectors [1] - On September 17, a total of 67 listed companies received broker recommendations, with Longbai Group, Sanhua Intelligent Control, and Hengsheng Silicon Industry each receiving 2 recommendations [1] - There were 3 instances of rating upgrades on September 17, including Huazhang Securities upgrading Dinglong Co., Ltd. from "Hold" to "Buy", Bohai Securities upgrading Hengrui Medicine from "Hold" to "Buy", and Huatai Financial Holdings (Hong Kong) upgrading Dongwei Semiconductor from "Hold" to "Buy" [1] Group 2 - On September 17, brokers initiated coverage on 7 companies for the first time, with Zhongfu Industrial and COFCO Sugar both receiving "Hold" ratings from Zhongyuan Securities, Shanshui Technology receiving a "Buy" rating from Northeast Securities, Hengrui Medicine receiving a "Buy" rating from Bohai Securities, and Kaipu Cloud receiving a "Buy" rating from Zheshang Securities [1]